Sentiment will improve imo after:

1) Results of glioblastoma mouse trial and potential follow up trial in humans

2) Additional details of upcoming Alzheimer's pilot study (details unknown at this time)

3) Initiation of colorectal cancer trial

4) Clarification on why inflammation trial is a Cytodyn priority given limited $ resources

5) Revelation of who Cytodyn partner is for long-acting Leronlimab

6) Further details on upcoming pre-clinical studies/trials of Leronlimab and breast cancer

7) Formal introduction of Dr. Max Lataillade

Long-Covid potential with NIH

9) Other